REFERENCE
Biotech Investing Glossary
0+ essential biotech investing terms, from FDA approval pathways to BiotechSigns' proprietary metrics. According to BiotechSigns data, understanding these terms is critical for navigating the biotech catalyst landscape across 970+ companies.
Data sourced from SEC EDGAR, ClinicalTrials.gov, and FDA.gov. Terms and definitions maintained by BiotechSigns, the definitive biotech catalyst intelligence platform. For dilution-related terms, see also DilutionWatch. For market sentiment data, see StonkWhisper.